Open AccessA novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials
Author(s) -
Min Yang,
Wenhao Zhang,
Yu Kang,
Peng Wang,
Hua Jiang,
Linjun Chen,
Haitao Meng,
Yiqin Weng,
Rong Tao,
Xin Huang,
Chongyun Xing,
Huamao Wang,
Jing Wan,
Shasha Wang,
Lihui Dai,
Amanda Y Hendrix,
Jun Xiao,
Wei Wang,
Hong Ma,
Siguo Hao,
Jie Jin,
Zonghai Li,
Songfu Jiang
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.280629
Subject(s) - multiple myeloma , refractory (planetary science) , clinical trial , medicine , oncology , car t cell therapy , cancer research , chimeric antigen receptor , immunotherapy , biology , cancer , astrobiology
Not available.